Genmab "AI Everywhere" rollout: enterprise ChatGPT expansion and 100+ custom GPTs for biotech

TL;DR

Genmab has rolled out “AI Everywhere,” expanding ChatGPT Enterprise to over 2,000 employees and deploying more than 100 custom GPTs to accelerate research, documentation, and translation, saving each user an average of 3.5 hours per week.

Overview of the "AI Everywhere" Initiative

Genmab, a global biotechnology firm, announced the "AI Everywhere" program to embed AI across all functions. The rollout builds on an earlier deployment of ChatGPT Enterprise to 1,000 staff and now provides access to more than 2,000 licenses. The initiative aims to improve scientific quality, decision‑making speed, and operational efficiency.

Scale of Adoption and Reported Impact

  • Licenses: Over 2,000 ChatGPT Enterprise licenses are active across the company.
  • Custom GPTs: More than 100 bespoke GPTs support tasks such as document drafting, literature summarization, and advanced data analytics.
  • User Engagement: Each employee averages 120 ChatGPT Enterprise conversations per week.
  • Time Savings: Internal surveys indicate an average weekly saving of 3.5 hours per employee.

“Learning to use ChatGPT has been a transformative journey for our employees. Our comprehensive training programs and personalized guidance have empowered them to embrace innovative ways of thinking and problem‑solving.” – Farhat Siddiqui, ChatGPT Product Manager, Genmab

Technical Highlights

GPT‑4o Vision Enhancements

Genmab leverages the newly released GPT‑4o vision capabilities to process documents that combine images, text, and numeric data. This enables rapid verification of factual references in medical affairs publications, a task that previously required extensive manual effort.

Clinical Document Generation

Using GPT‑4o, Genmab automates the creation of clinical trial documents—including clinical study reports, patient safety narratives, and IND applications. The model is integrated with live clinical data and feedback loops, allowing it to iteratively improve drafts in a manner akin to human problem solving.

AI Translator GPT

The AI Translator GPT translates complex scientific texts with human‑level accuracy. It simulates a translation team (translator, editor, specialist) and employs a reverse‑translation check to identify information loss. For English‑to‑Chinese translations, the system can route through Japanese as a staging language, cutting translation time from weeks to hours or minutes and reducing costs dramatically.

Partnership with OpenAI

Genmab chose a direct partnership with OpenAI over a generic cloud provider to gain access to OpenAI’s applied research and deployment expertise. This collaboration supports joint development of new AI‑driven solutions and ensures that Genmab can influence the evolution of the models to meet biopharma needs.

“We considered working with a cloud provider, but value the direct relationship with OpenAI. By working with the OpenAI team, we have access to the applied, research and deployment organizations that can partner with us on new initiatives and push the capabilities of our solutions.” – Hisham Hamadeh, Senior Vice President and Global Head of Data Sciences & AI, Genmab

Governance, Security, and Risk Management

Before deployment, Genmab evaluated OpenAI’s security and data‑privacy controls. The company conducts periodic reviews to ensure compliance, responsible use, and transparency of the AI tools.

Implications for the Biopharma Industry

Genmab’s extensive AI integration demonstrates how large language models can streamline drug discovery, development, and regulatory documentation. The reported productivity gains suggest that similar AI‑first strategies could become a competitive differentiator across the biopharmaceutical sector.

“Our vision goes beyond just streamlining processes; we’re aiming to fundamentally transform how we discover, develop, and deliver treatments to patients.” – Scott Ogden, Head of Genmab’s AI Lab

Key Takeaways

  • Enterprise‑wide AI rollout: Over 2,000 employees now have ChatGPT Enterprise access.
  • Custom tooling: 100+ specialized GPTs address scientific, analytical, and translation workflows.
  • Quantified efficiency: Average weekly time savings of 3.5 hours per user.
  • Strategic partnership: Direct collaboration with OpenAI provides tailored research and deployment support.
  • Industry impact: Sets a precedent for AI‑driven transformation in drug development and biopharma operations.

Sources